Universal Immunisation Programme

Last updated

Universal Immunisation Programme (UIP) is a vaccination programme launched by the Government of India in 1985. [1] It became a part of Child Survival and Safe Motherhood Programme in 1992 and is currently one of the key areas under the National Health Mission since 2005. The programme now consists of vaccination for 12 diseases- tuberculosis, diphtheria, pertussis (whooping cough), tetanus, poliomyelitis, measles, hepatitis B, rotaviral gastroenteritis, Japanese encephalitis, rubella, pneumonia (haemophilus influenzae type B) and Pneumococcal diseases (pneumococcal pneumonia and meningitis). Hepatitis B and Pneumococcal diseases [2] were added to the UIP in 2007 and 2017 respectively. [3] [4] The cost of all the vaccines are borne entirely by the Government of India and is funded through taxes with a budget of ₹7,234 crore (US$870 million) in 2022 and the program covers all residents of India, including foreign residents. [5]

Contents

The other additions in UIP through the way are inactivated polio vaccine (IPV), rotavirus vaccine (RVV), Measles-Rubella vaccine (MR). Four new vaccines have been introduced into the country's Universal Immunisation Programme (UIP), including injectable polio vaccine, an adult vaccine against Japanese Encephalitis and Pneumococcal Conjugate Vaccine.[ citation needed ]

Background

Vaccines against rotavirus, rubella and polio (injectable) will help the country meet its Millennium Development Goals 4 targets that include reducing child mortality by two-thirds by 2015, besides meeting meet global polio eradication targets. An adult vaccine against Japanese encephalitis was also introduced in districts with high levels of the disease. The recommendations to introduce these new vaccines have been made after numerous scientific studies and comprehensive deliberations by the National Technical Advisory Group of India (NTAGI), the country's apex scientific advisory body on immunisation.[ citation needed ]

Vaccine benefits are debated with some urging caution in the choice of vaccines introduced while expanding the immunisation programme, despite overwhelming and widespread documented scientific evidence on the efficacy of vaccines. [6]

With these new vaccines, India's UIP will now provide universal and free vaccines against 13[ citation needed ] life-threatening diseases, to 27 million children annually. Calling it one of the most significant health policies in the last 30 years, the note pointed out that the latest decision along with the recently introduced pentavalent vaccine, will help prevent death in about one lakh infants and adults in the working age group, besides putting a stop to about 10 lakh hospitalizations each year.[ citation needed ]

"The introduction of four new lifesaving vaccines, will play a key role in reducing the childhood and infant mortality and morbidity in the country. Many of these vaccines are already available through private practitioners to those who can afford them. The government will now ensure that the benefits of vaccination reach all sections of the society, regardless of social and economic status," the PM said. [7]

From February 2017, Union ministry of health and family welfare has rolled out Measles-Rubella vaccine from UIP. [8]

See also

Related Research Articles

<span class="mw-page-title-main">Rubella</span> Human viral disease

Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and last for three days. It usually starts on the face and spreads to the rest of the body. The rash is sometimes itchy and is not as bright as that of measles. Swollen lymph nodes are common and may last a few weeks. A fever, sore throat, and fatigue may also occur. Joint pain is common in adults. Complications may include bleeding problems, testicular swelling, encephalitis, and inflammation of nerves. Infection during early pregnancy may result in a miscarriage or a child born with congenital rubella syndrome (CRS). Symptoms of CRS manifest as problems with the eyes such as cataracts, deafness, as well as affecting the heart and brain. Problems are rare after the 20th week of pregnancy.

<span class="mw-page-title-main">Immunization</span> Process by which an individuals immune system becomes fortified against an infectious agent

Immunization, or immunisation, is the process by which an individual's immune system becomes fortified against an infectious agent. When this system is exposed to molecules that are foreign to the body, called non-self, it will orchestrate an immune response, and it will also develop the ability to quickly respond to a subsequent encounter because of immunological memory. This is a function of the adaptive immune system. Therefore, by exposing a human, or an animal, to an immunogen in a controlled way, its body can learn to protect itself: this is called active immunization. The most important elements of the immune system that are improved by immunization are the T cells, B cells, and the antibodies B cells produce. Memory B cells and memory T cells are responsible for a swift response to a second encounter with a foreign molecule. Passive immunization is direct introduction of these elements into the body, instead of production of these elements by the body itself.

This is a timeline of the development of prophylactic human vaccines. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became available on the market. Although vaccines exist for the diseases listed below, only smallpox has been eliminated worldwide. The other vaccine-preventable illnesses continue to cause millions of deaths each year. Currently, polio and measles are the targets of active worldwide eradication campaigns.

ATC code J07Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup J07 is part of the anatomical group J Antiinfectives for systemic use.

<span class="mw-page-title-main">Pulse Polio</span> Indian governmental immunisation campaign

Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus. The project fights polio through a large-scale, pulse vaccination programme and monitoring for poliomyelitis cases.

<span class="mw-page-title-main">Vaccination schedule</span> Series of vaccinations

A vaccination schedule is a series of vaccinations, including the timing of all doses, which may be either recommended or compulsory, depending on the country of residence. A vaccine is an antigenic preparation used to produce active immunity to a disease, in order to prevent or reduce the effects of infection by any natural or "wild" pathogen. Vaccines go through multiple phases of trials to ensure safety and effectiveness.

<span class="mw-page-title-main">Childhood immunizations in the United States</span>

The schedule for childhood immunizations in the United States is published by the Centers for Disease Control and Prevention (CDC). The vaccination schedule is broken down by age: birth to six years of age, seven to eighteen, and adults nineteen and older. Childhood immunizations are key in preventing diseases with epidemic potential.

The MMRV vaccine is a combination vaccine which combines the attenuated virus measles, mumps, rubella, and varicella (chickenpox). The MMRV vaccine has similar immunogenicity and overall safety profiles to the MMR vaccine administered with or without the varicella vaccine. The MMRV vaccine is typically given to children between one and two years of age.

<span class="mw-page-title-main">Pneumococcal vaccine</span> Vaccine to prevent infection by the bacteria Stretococcus pneumoniae

Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide vaccines. They are given by injection either into a muscle or just under the skin.

<span class="mw-page-title-main">Ciro de Quadros</span> Brazilian physician

Ciro Carlos Araujo de Quadros was a Brazilian leader in the field of Public Health, in particular, the area of vaccines and preventable diseases. He was born in Rio Pardo, Brazil.

A vaccination policy is a health policy adopted in order to prevent the spread of infectious disease. These policies are generally put into place by state or local governments, but may also be set by private facilities, such as workplaces or schools. Many policies have been developed and implemented since vaccines were first made widely available.

A vaccine-preventable disease is an infectious disease for which an effective preventive vaccine exists. If a person acquires a vaccine-preventable disease and dies from it, the death is considered a vaccine-preventable death.

The Rostropovich-Vishnevskaya Foundation (RVF) is a non-profit organization based in Washington, D.C. that supports programs to improve the health of children worldwide.

A Vaccine Information Statement (VIS) is a document designed by the Centers for Disease Control and Prevention (CDC) to provide information to a patient receiving a vaccine in the United States. The National Childhood Vaccine Injury Act requires that medical professionals provide a VIS to patients before receiving certain vaccinations. The VIS includes information about the vaccine's benefits and risks, a description of the vaccine, indications and contraindications, instructions for patients experiencing an adverse reaction, and additional resources.

<span class="mw-page-title-main">GAVI</span> Global health organization

GAVI, officially Gavi, the Vaccine Alliance is a public–private global health partnership with the goal of increasing access to immunization in poor countries. In 2016, Gavi channeled more than half of total donor assistance for health, and most donor assistance for immunization, by monetary measure.

<span class="mw-page-title-main">Mission Indradhanush</span> Health mission of the government of India

Mission Indradhanush is a health mission of the Government of India. It was launched by Union Health Minister J. P. Nadda on 25 December 2014. The scheme this seeks to drive towards 90% full immunisation coverage of India and sustain the same by year 2022. Vaccination is being provided against eight vaccine-preventable diseases nationally, i.e. Diphtheria, Whooping Cough, Tetanus, Polio, Measles, severe form of Childhood Tuberculosis and Hepatitis B and meningitis & pneumonia caused by Haemophilus influenza type B; and against Rotavirus Diarrhea and Japanese Encephalitis in selected states and districts respectively.

<span class="mw-page-title-main">National Immunisation Program</span> Australian population vaccination program

The National Immunisation Program (NIP) and National Immunisation Program Schedule is the national vaccination schedule for all children and adults in Australia. The program is a joint federal, state and territory government initiative that funds all vaccinations on the schedule for all people eligible for Medicare. It aims to reduce the prevalence of preventable diseases and increase vaccination coverage in the Australian population. NIP-funded vaccines are available through general practices, local council and community health clinics, Aboriginal Community Controlled Health Services and pharmacies. Like all vaccinations, schedule immunisations are not mandatory, although some additional government benefits and early education providers require vaccination or an approved exemption.

<span class="mw-page-title-main">Vaccination in India</span>

Vaccination in India includes the use of vaccines in Indian public health and the place of vaccines in Indian society, policy, and research.

<span class="mw-page-title-main">Shabir Madhi</span> South African physician and professor

Shabir Ahmed Madhi, is a South African physician who is professor of vaccinology and director of the South African Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, and National Research Foundation/Department of Science and Technology Research Chair in Vaccine Preventable Diseases. In January 2021, he was appointed Dean of the Faculty of Health Sciences at the University of the Witwatersrand.

<span class="mw-page-title-main">The Green Book (immunisation guidance, UK)</span> Book about vaccination

Immunisation against infectious disease, popularly known as The Green Book, provides information on vaccines for vaccine-preventable diseases. It acts as a guide to the UK's vaccination schedule for health professionals and health departments that give vaccines in the United Kingdom.

References

  1. ↑ "Immunization :: National Health Mission". nhm.gov.in. Retrieved 11 January 2021.
  2. ↑ "Shri J P Nadda launches Pneumococcal Conjugate Vaccine (PCV) under Universal Immunization Programme (UIP)". pib.nic.in. Retrieved 2017-05-30.
  3. ↑ "Archived copy" (PDF). Archived from the original (PDF) on March 1, 2013. Retrieved March 9, 2013.{{cite web}}: CS1 maint: archived copy as title (link)
  4. ↑ Patra, Nilanjan. "UNIVERSAL IMMUNIZATION PROGRAMME IN INDIA: THE DETERMINANTS OF CHILDHOOD IMMUNIZATION" (PDF). Indian Statistical Institute, Calcutta. p. 1. Retrieved 1 February 2012.
  5. ↑ Chatterjee, Susmita; Pant, Manish; Haldar, Pradeep; Aggarwal, Mahesh Kumar; Laxminarayan, Ramanan (June 2016). "Current costs & projected financial needs of India's Universal Immunization Programme". The Indian Journal of Medical Research. 143 (6): 801–808. doi: 10.4103/0971-5916.192073 . ISSN   0971-5916. PMC   5094121 . PMID   27748306.
  6. ↑ Andre F; Booy R; Bock H (2008). "Vaccination greatly reduces disease, disability, death and inequity worldwide". Bulletin of the World Health Organization. 86 (2): 140–146. doi:10.2471/BLT.07.040089 (inactive 5 December 2024). PMC   2647387 . PMID   18297169.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link)
  7. ↑ "Govt adds 4 vaccines to immunisation programme". Livemint. July 3, 2014. Retrieved February 18, 2017.
  8. ↑ Ghosh, Abantika (January 10, 2017). "Measles-rubella vaccine to roll out in February". The India Express. Retrieved February 18, 2017.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.